UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of: November 2018

Commission File Number: 001- 37413

Concordia International Corp.

(Translation of registrant’s name into English)

5770 Hurontario Street, Suite 310, Mississauga, Ontario, L5R 3G5

Mississauga, Ontario, L5R 3G5

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

On November 814, 2018, Concordia International Corp. (~~the~~ “~~Corporation~~Concordia”) ~~filed~~released aits ~~proxy~~third ~~circular~~quarter ~~and accompanying materials on the System for Electronic Document Analysis and Retrieval (SEDAR) in Canada, in connection with the special meeting of shareholders being held on November 29,~~ 2018 results. In conjunction with this ~~filing~~release ~~the~~Concordia ~~Corporation~~ is filing the following exhibits:

Exhibit 99.1 ~~Notice~~Press ofrelease ~~Meeting for the Special Meeting~~ of ~~Shareholders~~Concordia toInternational beCorp., ~~held~~dated on November 2914, 2018.

Exhibit 99.2 Management’s ~~Information~~Discussion ~~Circular~~and ~~dated~~Analysis ~~October~~of ~~30,~~Financial ~~2018,~~Condition ~~with~~and ~~respect~~Results toof ~~the~~Operations ~~Special~~for ~~Meeting~~the ofthree ~~Shareholders~~and tonine bemonths ~~held~~ended onSeptember ~~November 29~~30, 2018.

Exhibit 99.3 ~~Form~~Unaudited ofCondensed ~~Proxy,~~Interim ~~with~~Consolidated ~~respect~~Financial toStatements ~~the~~as ~~Special~~at ~~Meeting~~and offor ~~Shareholders~~the tothree beand ~~held~~nine onmonths ~~November~~ended 29September 30, 2018.

~~Exhibit~~This ~~99.4~~report ~~Voting~~on ~~Instruction~~ Form, ~~with~~6-K ~~respect~~shall be deemed to ~~the~~be ~~Special~~incorporated ~~Meeting~~by ofreference ~~Shareholders~~into Concordia’s Registration Statements on Form S-8 (File No. 333-209498) and to be ~~held~~a part thereof from the date on ~~November~~which 29this report is filed, ~~2018~~to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



Concordia International Corp.


By:	/s/ Adeel Ahmad
	Name:	Adeel Ahmad
	Title:	Chief Financial Officer

Date: November 814, 2018

EXHIBIT INDEX

Exhibit No.		Description
99.1		Notice of Meeting for the Special Meeting of Shareholders to be held on November 29, 2018.
99.2		Management Information Circular dated October 30, 2018, with respect to the Special Meeting of Shareholders to be held on November 29, 2018.
99.3		Form of Proxy, with respect to the Special Meeting of Shareholders to be held on November 29, 2018.
99.4		Voting Instruction Form, with respect to the Special Meeting of Shareholders to be held on November 29, 2018.


Exhibit No.	Description


Exhibit 99.1	Press release of Concordia International Corp., dated November 14, 2018.


Exhibit 99.2	Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2018.


Exhibit 99.3	Unaudited Condensed Interim Consolidated Financial Statements as at and for the three and nine months ended September 30, 2018.

Filing Compare · ADVANZ PHARMA Corp.